HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Circulating Betatrophin Is Strongly Increased in Pregnancy and Gestational Diabetes Mellitus.

AbstractAIMS/HYPOTHESIS:
Betatrophin has recently been introduced as a novel hormone and promotor of beta cell proliferation and improved glucose tolerance in mouse models of insulin resistance. In obese and diabetic humans altered levels were reported and a role in pathophysiology of metabolic diseases was therefore hypothesized. However its release and regulation in women with gestational diabetes mellitus (GDM), as well as its associations with markers of obesity, glucose and lipid metabolism during pregnancy still remain unclear.
METHODS:
Circulating betatrophin was quantified in 21 women with GDM and 19 pregnant body mass index-matched women with normal glucose tolerance (NGT) as well as 10 healthy age-matched non-pregnant women by enzyme-linked immunosorbent assay. Additionally we performed radioimmunassay (RIA) to confirm the results.
RESULTS:
Betatrophin concentrations measured by ELISA were significantly higher in GDM than in NGT (29.3±4.4 ng/ml vs. 18.1±8.7 ng/ml, p<0.001) which was confirmed by RIA. Betatrophin did not correlate with BMI or insulin resistance but showed a weak association with leptin levels in pregnancy and negative relationship with fasting C-peptide levels in all women. Moreover it correlated significantly with lipid parameters including triglycerides and total cholesterol in pregnancy, as well as estrogen, progesteron and birth weight.
CONCLUSIONS/INTERPRETATION:
Circulating betatrophin concentrations are dramatically increased in pregnancy and are significantly higher in GDM versus pregnant NGT. In the light of the previously reported role in lipid metabolism, betatrophin may represent a novel endocrine regulator of lipid alterations in pregnancy. However additional studies are needed to elucidate whether hormonal factors, such as estrogen, control the production of betatrophin and if targeting betatrophin could hold promise in the fight against metabolic disease.
AuthorsLana Kosi Trebotic, Peter Klimek, Anita Thomas, Anna Fenzl, Karoline Leitner, Stefanie Springer, Florian W Kiefer, Alexandra Kautzky-Willer
JournalPloS one (PLoS One) Vol. 10 Issue 9 Pg. e0136701 ( 2015) ISSN: 1932-6203 [Electronic] United States
PMID26325425 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ANGPTL8 protein, human
  • Angiopoietin-Like Protein 8
  • Angiopoietin-like Proteins
  • Peptide Hormones
Topics
  • Adult
  • Angiopoietin-Like Protein 8
  • Angiopoietin-like Proteins
  • Body Mass Index
  • Case-Control Studies
  • Diabetes, Gestational (blood)
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Glucose Tolerance Test
  • Humans
  • Peptide Hormones (blood)
  • Pregnancy (blood)
  • Radioimmunoassay

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: